Inferring the activity of transcription factors in single cells is a key task to improve our 2 0 4 1 relationships function at the single-cell level and therefore their implications can only be truly 4 2 understood at single-cell resolution 3-8 . 4 3 Recent single-cell RNA-sequencing (scRNA-Seq) studies have significantly advanced our 4 4 understanding of cellular development and disease 4, 7, 9-29 , yet how best to infer regulatory 4 5 activity at the single-cell level is still unclear. While a number of methods for inferring 4 6 regulatory activity have appeared 30-32 , all attempt to do so by first inferring the regulatory 4 7
Introduction 3 6
Transcription factors play key roles in cellular development, and the regulatory networks they To test SCIRA, we first considered the case of a developmental scRNA-Seq study in liver (range 10 to 151) (SI table S1, Methods). Among the 22 liver-specific TFs, were well-known 1 1 1 factors, such as Hnf1a, Hnf4a and Foxa1/Foxa2. We validated the regulons of the 22 TFs in 1 1 2 two independent datasets: the RNA-Seq multi-tissue set from the ProteinAtlas 42 project, and hepatoblasts to hepatocytes and cholangiocytes, SCIRA ought to predict this increased TF 1 1 6 activity in the scRNA-Seq study above. We applied SCIRA to the scRNA-Seq study, to infer 1 1 7 activity estimates for the 22 liver-specific TFs in each of the 447 single cells, which showed 1 1 8 that many of the TFs (e.g. Hnf1a) exhibited an increased activity pattern during the time 1 1 9 course, in line with their known role in liver specification ( Fig.2A, 2C) . This was not 1 2 0
observed had we used the expression values of the TFs themselves ( Fig.2B ). Of the 22 TFs, SCIRA can be used to identify novel dynamic patterns of regulatory activity at single-cell 3 0 2 resolution, despite using regulons inferred from bulk data.
3 0 3
In addition, we have also shown how SCIRA can lead to critical novel insights in a disease 3 0 4
context. The demonstration, at single cell resolution, that most of the lung-specific TFs are 3 0 5 inactivated specifically in the lung tumor epithelial cells is entirely novel. Although highly 3 0 6 consistent and expected given the analogous observations made at the bulk level (see e.g. 37, 3 0 7 51 ), it is not automatic that bulk and single-cell results would agree so well given the where over 40% of cells are stromal cells 60 . Many of the lung-specific TFs, which SCIRA 3 1 0 predicts to be inactivated in lung tumor epithelial cells (e.g. NKX2-1, FOXA2, FOXJ1, AHR, 3 1 1 HIF3A) implicate key cancer-pathways (lung differentiation, immune-response, 3 1 2 hypoxia-response), and their inactivation likely represents key driver events. Supporting this, 3 1 3 epigenetically induced silencing of NKX2-1 has recently been proposed to be a key driver Finally, it is important to discuss in more detail the comparison between SCIRA and SCENIC. Based on our high-confidence tissue-specific regulatory networks, we estimated the 3 1 7 sensitivity of SCENIC to detect true regulatory activity patterns to be less than 5%. tissue-centric approach, and therefore the need to build a tissue-specific regulatory network repertoire of transcription factors. As such, SCIRA provides a flexible and easily 3 3 0 generalizable framework in which to infer regulatory activity in single-cells. In summary, our study has demonstrated that using TF-regulons can help overcome the high 3 3 3 dropout rate of scRNA-Seq data, to enable accurate estimation of TF-activity in single cells. The quality of the TF-regulons is key to the reliability of the inference, and we have shown We analyzed scRNA-Seq data from a total of 3 studies: transformed basis. After quality control, there are a total of 201 single cells assayed at 4 3 5 0 different stages in the developing mouse lung epithelium, including embryonic day E14.5 (n 3 5 1 = 45), E16.5 (n = 27), E18.5 (n = 83) and adulthood (n = 46). as normal epithelial, yet they derived from a malignant sample 50 , so given this inconsistency 3 6 8
we removed these cells from any analysis, as according to us their "normal" nature is far and was therefore considered most representative of the normal epithelial cells found in lung. We used the bulk RNA-Seq dataset from the GTEX resource 36 . Specifically, the normalized 3 7 4
RPKM data was downloaded from the GTEX website and annotated to Entrez gene IDs. Data was then log 2 transformed with a pseudocount of +1. This resulted in a data matrix of 23929 The SCIRA algorithm has two main steps: (i) construction of a tissue-specific regulatory (TFs) in the network constructed in step (i). corresponding tissue-specific regulatory network using our SEPIRA algorithm 37 . Briefly, 3 8 9
SEPIRA implements a greedy partial correlation approach to infer a partial correlation 3 9 0 network between regulators (TFs) and potential gene targets using the large GTEX 3 9 1 cross-tissue dataset described above. The greedy partial correlation approach is similar in 3 9 2 concept to the GENIE3 algorithm 38 (which was found to be one of the best performing regulators for each gene in turn. SEPIRA however does this using partial correlations instead it is possible to identify direct regulatory relations that are relevant in the context of TFs with significantly higher expression in the given tissue type compared to all other tissues combined. This is done using the empirical Bayes moderated t-test framework (limma) 61 .
Importantly, a second limma analysis is performed by comparing the tissue of interest to 40% of all cells found in liver 60 . We require a liver-specific TF to be one with significantly where the IC infiltration may be low. As applied to liver, SEPIRA inferred a network of 22 The same procedure was used for lung, as described in our earlier work 37 , resulting in a normalized scRNA-Seq dataset is z-score normalized, i.e. each gene is centred and scaled to 4 2 5 unit standard deviation.
2 6
We note that SCIRA relies on the high-quality tissue-specific regulatory network inferred in 4 2 7
step-1. As such, SCIRA is particularly useful for scRNA-Seq studies that profile cells in the 4 2 8
tissue of interest, either as part of a developmental or differentiation timecourse experiment,
or in the context of diseases where altered differentiation is a key disease hallmark e.g. cancer
and precursor cancer lesions. We used the following strategy to estimate the sensitivity of SEPIRA/SCIRA to detect highly sizes, we note that the median number of samples per tissue-type in GTEX is approximately
170. We therefore took a more conservative value of 150 to represent the number of samples were not in the RIKEN lab list. GENIE3 was run with default parameter choices 4 6 6 (treeMethod="RF", K="sqrt", nTrees=1000) but on a reduced data matrix where genes with a 4 6 7 standard deviation less than 0.5 were removed. Regulons of TFs were obtained from GENIE3 were selected using a Spearman correlation coefficient threshold > 0. In SCENIC, the targets 4 7 0 are then scanned for enriched binding motifs using RcisTarget. We used the 7species.mc9nr GENIE3, and only those that overlapped were considered valid TF regulons. For these we 4 7 5
then estimated a regulatory activity score using an approach similar to the one implemented 4 7 6
in AUCell, but one that is threshold independent, and therefore an improvement over the 4 7 7 method used in AUCell. Specifically, the activity score was defined as the AUC of a and from ArrayExpress (www.ebi.ac.uk/arrayexpress) accession numbers: E-MTAB-6149. (NAF award number: 164914). We would also like to thank Peter Kharchenko and John 5 0 4
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